NDC 51672-1402-08 - Calcipotriene and Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1402
- Requested NDC
- 51672-1402-08
- Package NDCs from labels
- 51672-1402-4, 51672-1402-8, 51672-1402-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MINERAL OIL - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | SUSPENSION | 1 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 2 in 1 CARTON | SUSPENSION | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1402 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20200904_1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Direct Rx | bbf26437-c9b4-d8e6-e053-2a95a90a0062 | 2025-01-17 | Warnings, Adverse reactions | 826Y60901U |
| Sunmark Mineral Oil Laxative | MINERAL OIL | Strategic Sourcing Services | c54f7df2-3845-425f-b13e-3dc000123f3c | 2025-01-14 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Chain Drug Marketing Association Inc. | 2b490a08-149d-76ab-e063-6394a90a084f | 2025-01-09 | Warnings | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Safecor Health, LLC | ef182484-692e-4eb3-bcf1-3c990ec0d08e | 2025-01-08 | Warnings | T5L8T28FGP |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Advanced Rx Pharmacy of Tennessee, LLC | fe2ec7d2-23c2-e99f-e053-6294a90aa65a | 2024-12-31 | Warnings, Adverse reactions | 826Y60901U |
| Lubricant Eye PM | MINERAL OIL, WHITE PETROLATUM | Reliable 1 Laboratories LLC | baec8045-97fe-6f60-e053-2a95a90a050e | 2024-12-31 | Warnings | T5L8T28FGP |
| AD Medicated Rash | AD MEDICATED RASH | WellSpring Pharmaceutical Corporation | aac345bf-ea66-4f5b-a497-c24ea72f93ea | 2024-12-27 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Pharmacy Value Alliance, LLC | 3803a61b-308a-14a9-e054-00144ff88e88 | 2024-12-20 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | T5L8T28FGP |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | T5L8T28FGP |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | T5L8T28FGP |
| Dr. Butler Soothing Incontinence | PETROLATUM 36% | Beyond Health P.A. | d17a0c28-a5b7-4df0-e053-2995a90a8edd | 2024-12-15 | Warnings | T5L8T28FGP |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Northstar Rx LLC. | 395d40c0-22d9-48d1-8d8e-eeaddf33c53e | 2024-12-05 | Adverse reactions | 826Y60901U |
| Systane Nighttime | MINERAL OIL AND WHITE PETROLATUM | Alcon Laboratories, Inc. | 4689c59c-5721-3f91-6c85-e41501998fd0 | 2024-12-05 | Warnings | T5L8T28FGP |
| GenTeal Tears NIGHT-TIME | MINERAL OIL, WHITE PETROLATUM | Alcon Laboratories, Inc. | 9d5998a7-4f59-4293-87da-8419650a524d | 2024-12-05 | Warnings | T5L8T28FGP |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Burel Pharmaceuticals, LLC | c8bda9a8-4dec-4084-84e5-4b4623390bd8 | 2024-12-04 | Warnings, Adverse reactions | 826Y60901U |
| Pure and Gentle | MINERAL OIL | Medline Industries, LP | 96d4cad5-0602-4c31-94ed-3117b4fd4a94 | 2024-11-26 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.